Neurology · Fort Worth, TX
Neurology studies in Fort Worth, TX
7 recruiting studies have a site in Fort Worth.
7 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingHealthy volunteersPhase 1
Exploration of an Online Education Program to Support Caregivers' Knowledge Transfer
Texas Christian University
- Location
- Fort Worth, TX
- Eligibility basics
- Ages 18+
- RecruitingPhase 1/Phase 2
A Clinical Study to Evaluate the Safety and Efficacy of ETX101 in Infants and Children With SCN1A-Positive Dravet Syndrome
Encoded Therapeutics
- Location
- Fort Worth, TX + 9 other US sites
- Eligibility basics
- Ages 6 mo–17
- RecruitingPhase 3
Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
Hoffmann-La Roche
- Location
- Fort Worth, TX + 67 other US sites
- Eligibility basics
- Ages 50–90
- RecruitingPhase 3
Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.
Novartis Pharmaceuticals
- Location
- Fort Worth, TX + 42 other US sites
- Eligibility basics
- Ages 40–70
- RecruitingPhase 3
Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy
Vertex Pharmaceuticals Incorporated
- Location
- Fort Worth, TX + 69 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingPhase 2
A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Diabetic Peripheral Neuropathic Pain
Eli Lilly and Company
- Location
- Fort Worth, TX + 35 other US sites
- Eligibility basics
- Ages 18+
- RecruitingHealthy volunteers
GABA Biomarkers in Dravet Syndrome
Cook Children's Health Care System
- Location
- Fort Worth, TX
- Eligibility basics
- Up to age 18
Who these studies look for
Most require a confirmed diagnosis; memory studies often ask for a study partner who knows you well to attend some visits.
Matching a page like this one never means you qualify. Each research team decides eligibility at screening.